Effect of intracapsular triamcinolone injection in treatment of capsular contracture after augmentation mammoplasty

Lee, Sangdal

Abstract

PURPOSE
The main problem for reoperation after augmentation mammoplasty is contraction of the capsule surrounding a breast implant and it tends to be recur after second surgery. The author studied that intracapsular injection of triamcinolone could reduce the recurrence of capsular contracture. METHODS: Twenty-six cases of capsular contracture, undertaken at the M.D. Clinic between July 2002 and August 2004, were reviewed. Age, types of previous implant, reoperation methods including triamcinolone injection, and recurrence rates were retrospectively evaluated. RESULTS: Two cases (7.7%) were in their twenties, 14 (53.9%) in their thirties, 7 (26.9%) in their forties and 3 (11.5%) in their fifties. The types of previous implant were as followed: 24 (92.3%) saline, 2 (7.7%) silicone gel, 14 (53.9%) textured type and 12 (46.1%) smooth type. The reoperation methods were as followed: capsulectomy in 4 (15.4%), subpectoral conversion in 1 (3.9%), subpectoral conversion with an intracapsule injection of triamcinolone in 2 (7.7%), capsulotomy in 7 (26.9%) and capsulotomy with an intracapsule injection of triamcinolone in 12 (46.2%). Recurrence occurred in 1 capsulectomy (25%), 1 subpectoral conversion (100%), 0 subpectoral conversion with injection (0%), 4 capsulotomy (57%) and 1 capsulotomy with injection (8.3%). CONCLUSION: The injection of triamcinolone into the capsule following an implant replacement was effective in patients with a capsular contracture after augmentation mammoplasty. It seems to be an effective rational therapy for primary high risk cases with more advanced technique.